BlackRock’s Anixa Biosciences ANIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$526K Sell
159,468
-35,955
-18% -$119K ﹤0.01% 4356
2025
Q1
$559K Buy
195,423
+12,391
+7% +$35.4K ﹤0.01% 4322
2024
Q4
$425K Buy
183,032
+20,691
+13% +$48K ﹤0.01% 4397
2024
Q3
$511K Buy
162,341
+1,925
+1% +$6.06K ﹤0.01% 4268
2024
Q2
$355K Buy
160,416
+5,754
+4% +$12.7K ﹤0.01% 4376
2024
Q1
$483K Sell
154,662
-2,135
-1% -$6.66K ﹤0.01% 4318
2023
Q4
$608K Sell
156,797
-4,769
-3% -$18.5K ﹤0.01% 4309
2023
Q3
$528K Sell
161,566
-90,004
-36% -$294K ﹤0.01% 4342
2023
Q2
$805K Buy
251,570
+4,210
+2% +$13.5K ﹤0.01% 4256
2023
Q1
$1.06M Sell
247,360
-46,859
-16% -$201K ﹤0.01% 4237
2022
Q4
$1.25M Sell
294,219
-3,294
-1% -$14K ﹤0.01% 4258
2022
Q3
$1.46M Buy
297,513
+195,603
+192% +$963K ﹤0.01% 4255
2022
Q2
$311K Sell
101,910
-54
-0.1% -$165 ﹤0.01% 4821
2022
Q1
$279K Sell
101,964
-3,204
-3% -$8.77K ﹤0.01% 4943
2021
Q4
$312K Sell
105,168
-5,124
-5% -$15.2K ﹤0.01% 4928
2021
Q3
$525K Sell
110,292
-7,737
-7% -$36.8K ﹤0.01% 4678
2021
Q2
$458K Buy
118,029
+15,809
+15% +$61.3K ﹤0.01% 4643
2021
Q1
$478K Buy
102,220
+8,278
+9% +$38.7K ﹤0.01% 4551
2020
Q4
$289K Buy
93,942
+6,964
+8% +$21.4K ﹤0.01% 4344
2020
Q3
$212K Sell
86,978
-1,201
-1% -$2.93K ﹤0.01% 4296
2020
Q2
$271K Buy
88,179
+8,198
+10% +$25.2K ﹤0.01% 4230
2020
Q1
$128K Sell
79,981
-1,117
-1% -$1.79K ﹤0.01% 4238
2019
Q4
$266K Sell
81,098
-4,891
-6% -$16K ﹤0.01% 4218
2019
Q3
$344K Buy
85,989
+6,315
+8% +$25.3K ﹤0.01% 4182
2019
Q2
$289K Buy
79,674
+29,823
+60% +$108K ﹤0.01% 4237
2019
Q1
$225K Sell
49,851
-2,545
-5% -$11.5K ﹤0.01% 4176
2018
Q4
$206K Buy
52,396
+263
+0.5% +$1.03K ﹤0.01% 4181
2018
Q3
$242K Buy
52,133
+6,565
+14% +$30.5K ﹤0.01% 4208
2018
Q2
$139K Buy
45,568
+40,748
+845% +$124K ﹤0.01% 4340
2018
Q1
$19K Hold
4,820
﹤0.01% 4520
2017
Q4
$11K Hold
4,820
﹤0.01% 4566
2017
Q3
$13K Hold
4,820
﹤0.01% 4581
2017
Q2
$6K Hold
4,820
﹤0.01% 4695
2017
Q1
$14K Buy
+4,820
New +$14K ﹤0.01% 4602